Lessons Learned

[Jackle]

Hi there,

Patent.
- The company is well aware, and by their calculations, on top of the patenting issue having been liaising with Patent lawyers Kilpatrick Townsend. Whilst patents are an inexact science Sigma management have been very conscious of the patent situation since I have been following them. They are very well entrenched now in the various top level projects in this space (America Makes, AMC/EWI and hopefully soon to be ONR) so their technology is well known, and established within the top tier companies. Never say never, but it’s a situation they are confidently aware of and have been for a long time.

Reading the board seems like the SGLB CEO & BOD (or whatever) are more interested in their own scientific notoriety than they are in making $---Do you get this impression ???
- No, reading too much into that board will drive you crazy. There is a lot of disinformation and lack of understanding. In my view the company has done an excellent job in moving from an R+D company towards a commercial one in an industry that is still evolving. Too many people want everything here and now and demand insider knowledge on everything for the relatively small investments. This is a highly technical, extremely specific area of a nascent industry. There is a lot going on behind the scenes and management has shown time and again that they are in tune with market direction, leaders and trends. They have been impressively sparing in burn rate, not leaping into overheads before they were ready. That is why the recent hires point to an interesting new phase of sales, one hopes. They hold regular conference calls where people are open to ask questions and provide timely financials. They have openly stated their intention to up list to a better exchange. They are much, much better and more professionally run than most OTC stocks by a country mile. To say they are only interested in their own scientific notoriety is just an embarrassing sign of ignorance. They are major stakeholders for heaven’s sake, of course they want the share price to do well.
GE buy out.
- PrintRite3D was developed as an INDEPENDENT tool in conjunction with GE and Honeywell. Three important features that make a play by one or other more complicated. I am sure Honeywell wouldn’t be too happy if GE tried to buy them out, and Vica-Versa. There is probably more value to all concerned in it to remain independent than to be incorporated into one company or another. Also there is the possibility that the $100m S-3 was drawn up as a poison pill against any kind of takeover. Not to say this kind of action will never happen, but it isn’t just a black and white certainty.

Bottom line is it looks like initial sales are very close but this industry takes TIME. With these sales, an uplist, some real investor money (basically no real funds can invest in OTC) and a bit of time Sigma looks in very good shape. Until that point will be more weird and wild gyrations on low liquidity in OTC land with people screaming about how terrible it is that management hasn’t informed them personally about every single piece of proprietary information in the NDA infested business world that this kind of tech lives in.

Regards